Eva Anette Engelhardt

EVP, President, CDG, Bio-Rad Laboratories.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Sep 6, 2026Shares withheld for tax 485 shares at $386.11 of Bio-Rad Laboratories²
Sep 6, 2026Exercised options 1,152 shares of Bio-Rad Laboratories²
Sep 5, 2026Shares withheld for tax 369 shares at $386.11 of Bio-Rad Laboratories²
Sep 5, 2026Exercised options 1,027 shares of Bio-Rad Laboratories²
Jul 25, 2026Shares withheld for tax 89 shares at $314.46 of Bio-Rad Laboratories³
Jul 25, 2026Exercised options 246 shares of Bio-Rad Laboratories³
May 11, 2026Sold 550 shares at $246.54 of Bio-Rad Laboratories⁴
Sep 6, 2025Shares withheld for tax 413 shares at $295.43 of Bio-Rad Laboratories⁵
Sep 6, 2025Exercised options 1,152 shares of Bio-Rad Laboratories⁵
Jul 25, 2025Shares withheld for tax 88 shares at $264.19 of Bio-Rad Laboratories⁶
Jul 25, 2025Exercised options 245 shares of Bio-Rad Laboratories⁶

Date	Stock	Trade	Value	Return since	Vs S&P since	Vs S&P, 1 year
May 11, 2026	BIO	Sale	$135.6K	+45.1%	−40.7%

Returns are price-only (no dividends), measured from the trade date.

The numbers on this page point here. Each one links to the record it came from.